Provision of Inherited White Matter Disorders Diagnostic and Management Service (IWMD) (All Ages) Reopened from previous EU Supply Reference 45233

NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.

This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.

New bidders are required to submit responses to all of the questions.

The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the "Regulations") to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the "Light Touch Regime").

The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

This project is split into 6 Lots, as detailed within the ITT documents.